0121-8123 0121-8123 S0121-81232021000100016 10.1016/j.rcreu.2020.06.004 Colombia 00 03 2021 00 03 2021 28 1 16 27

2003 30 1436-9 2010 69 522-8 2009 33 956-73 Targeted tuberculin testing and treatment of latent tuberculosis infection 2000 9 49 49 1-51.5 2015 372 2127-35 2003 163 1009-21 1974 99 131-8 2006 55 19-26 2008 20 443-9 American College of Rheumatology Subcommittee on Rheumatoid Arthritis Guidelines 2002 46 328-46 2002 359 540-1 2016 19 A224-5 2018 2018 362 k3015 2011 7 284-98 2012 39 1583-602 2005 27 425-8 2015 35 1555-9 2017 76 960-77 2013 601737 2008 3 Diagnostic standards and classification of tuberculosis in adults and children 2000 161 1376-95 2010 15 433-50 1992 148 2058-61 1975 293 501-2 1987 92 234-6 2005 20 2720-4 2003 59 436-40 1998 113 25-7 1998 31 848-52 1994 149 1699-709 2000 29 369-75 1978 42 84-113 1981 124 80-7 1911 VII 2 2 259-88 1989 2 576-8 1992 267 369-73 Pulmonary Complications of HIV Infection Study Group 1993 119 185-93 2005 9 977-84 1980 33 1608-11 2000 105 1317-25 1983 249 3209-11 1982 12 511-4 2015 4 80 2008 59 757-9 1961 14 597-607 1973 108 767-76 1952 24 533-9 1986 41 206-15 1987 45 177-83 1954 250 353-61 1964 34 2 2 216-7 1973 52 1-12 1983 26 102-10 1992 268 504-9 1983 158 1727-32 1977 60 247-53 The Pulmonary Complications of HIV Infection Study Group 1996 153 6 6 1982-4 1966 30 248-56 1951 32 516-29 1963 90 466-77 1983 15 369-72 1977 11 485 1998 44 56-60 2007 1109 235-9 2014 430134 1975 56 1587-96 2004 2 309-13 1976 69 424-6 1984 52 75-82 2017 64 111-5 2015 42 533-44 2012 64 625 2016 75 3-15 2009 49 2 2 121-5 2013 72 A48 2010 111 498-501 2016 68 1314-5 2003 48 2122-7 2012 71 1791-5 2012 71 1783-90 2012 71 1757-60 2014 91 41-6 1997 1 427-34 1954 250 353-61 1992 267 369 1987 92 237-40 2001 27 317-34 2005 64 1360-1 1963 91 846-50 1964 116 471-5 1968 3 91-8 2017 12 1 2018 48 538-46 1983 249 3209 2016 16 626-38 2018 21 1563-71